Endogena Therapeutics � Endogena IPF

Endogena Therapeutics, founded by Matthias Steger MD PhD, is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs that have deteriorated due to aging and genetic diseases. Endogena is working on a drug for ideopathi pulmonary fibrosis, a chronic and progressive lung disease, characterized by inflammation and subsequent scarring of the lung that leads to respiratory failure. It is a rare, age-related condition with unknown cause.